Genetek Lifesciences to manufacture Amphotericin B injection for black fungus treatment

On the initiative of Union Minister Nitin GadkariGenetek Lifesciences of Wardha has received FDA approval to make Amphotericin B injection for black fungus infection during the COVID-19 period, a statement issued by the minister’s office said. Its production will begin in the next 15 days at its Wardha plant.

Right now the cost of an injection is Rs 7,000 and people are not getting it easily.

The injection made in Wardha will be available for just Rs 1,200, it added.

A total of 20,000 injections per day will be manufactured in the plant.

Genetek Lifesciences started production of Remdesivir injections, used in the treatment of COVID-19, in Wardha from Wednesday.

The company has received a loan licence to manufacture Remdesivir.

  • Related Posts

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

    Pak-made illegal cosmetics recovered from Itwari shop

    Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Pak-made illegal cosmetics recovered from Itwari shop

    Pak-made illegal cosmetics recovered from Itwari shop

    Licences of 20 medical stores suspended after inspections

    Licences of 20 medical stores suspended after inspections

    Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

    Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    HP accounts for 47 inferior drugs in March alert

    HP accounts for 47 inferior drugs in March alert